Laurion Capital Management LP Imara Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.99 - $1.87 $153,631 - $290,192	-155,183 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $125,922 - $263,890	-109,498 Reduced 41.37%	155,183 $292,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $79,467 - $143,041	-35,319 Reduced 11.77%	264,681 $596,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $1.22 Million - $2.35 Million	300,000 New	300,000 $1.22 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.